Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,060 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials.
Galli M, Benenati S, Franchi F, Rollini F, Capodanno D, Biondi-Zoccai G, Vescovo GM, Cavallari LH, Bikdeli B, Ten Berg J, Mehran R, Gibson CM, Crea F, Pereira NL, Sibbing D, Angiolillo DJ. Galli M, et al. Eur Heart J. 2022 Mar 7;43(10):959-967. doi: 10.1093/eurheartj/ehab836. Eur Heart J. 2022. PMID: 34918066 Free PMC article.
Adenosine as adjunctive therapy in acute coronary syndrome: a meta-analysis of randomized controlled trials.
Laborante R, Bianchini E, Restivo A, Ciliberti G, Galli M, Vergallo R, Rodolico D, Zito A, Princi G, Leone AM, Aurigemma C, Romagnoli E, Montone RA, Burzotta F, Trani C, Crea F, D'Amario D. Laborante R, et al. Among authors: galli m. Eur Heart J Cardiovasc Pharmacother. 2023 Feb 2;9(2):173-182. doi: 10.1093/ehjcvp/pvac069. Eur Heart J Cardiovasc Pharmacother. 2023. PMID: 36496163
2,060 results